METHOD FOR THE PRODUCTION OF A SOLID, ORALLY APPLICABLE PHARMACEUTICAL COMPOSITION COMPRISING 5-Chlor-N ( { (5-2-oxo-3- [4- (3-oxo-4-morpholinyl)-phenyl]-1, 3- oxazolidin-5-yl}-methyl)-2-thiophencarboxamide

Production of solid, orally administered pharmaceutical compositions (A) containing 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidin-5-yl)-methyl)-2-thiophene-carboxamide (I) in hydrophilized form comprises: (a) preparing granules containing (I) in hydrophilized form by wet...

Full description

Saved in:
Bibliographic Details
Main Author BENKE, KLAUS
Format Patent
LanguageEnglish
Polish
Published 29.09.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Production of solid, orally administered pharmaceutical compositions (A) containing 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidin-5-yl)-methyl)-2-thiophene-carboxamide (I) in hydrophilized form comprises: (a) preparing granules containing (I) in hydrophilized form by wet granulation; and (b) converting the granules, optionally with suitable additives, into (A). Independent claims are included for: (1) the compositions (A) obtained by the process; and (2) solid, orally administered pharmaceutical compositions (A') containing (I) in hydrophilized form in general. ACTIVITY : Thrombolytic; Anticoagulant; Cardiant; Antianginal; Vasotropic; Cerebroprotective. MECHANISM OF ACTION : Coagulation factor Xa inhibitor.
AbstractList Production of solid, orally administered pharmaceutical compositions (A) containing 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidin-5-yl)-methyl)-2-thiophene-carboxamide (I) in hydrophilized form comprises: (a) preparing granules containing (I) in hydrophilized form by wet granulation; and (b) converting the granules, optionally with suitable additives, into (A). Independent claims are included for: (1) the compositions (A) obtained by the process; and (2) solid, orally administered pharmaceutical compositions (A') containing (I) in hydrophilized form in general. ACTIVITY : Thrombolytic; Anticoagulant; Cardiant; Antianginal; Vasotropic; Cerebroprotective. MECHANISM OF ACTION : Coagulation factor Xa inhibitor.
Author BENKE, KLAUS
Author_xml – fullname: BENKE, KLAUS
BookMark eNqNy81Og0AQB3AOevDrHcYbJp3EluLHcV1ANllYAtuDMabBds2SLCyhHFqNr-gzuTQ-gKf_zH9-c-6ddLZTZ95PFstURJCIEmQaQ1GKaEUlEzmIBAhUgrNoBqIknL8AKQrOKHniDqakzAiNV9IVHKjIClGx4-M0l6xi-TOESLWxA-bgwxf4IS7Q7i0GCK9LBD84bkts7dBra5ruYG6w18rlG85n4Jzd15_usm06DPFgvrFVo57YAkfd2Alv6uHdsbbZqkvv9KM2O3X1lxfedRJLmqLq7Vrt-nqjOjWuCz6_e3gM7m-lDIP_mF8M4lo_
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Sposób wytwarzania stałej, doustnej kompozycji farmaceutycznej zawierającej 5-chloro-N({(5S)-2-okso-3-[4-(3-okso-4-morfolinylo)fenylo]-1,3-oksazolidyn-5-ylo}mety-lo)-2-tiofenokarboksyamid
ExternalDocumentID PL1689370TT5
GroupedDBID EVB
ID FETCH-epo_espacenet_PL1689370TT53
IEDL.DBID EVB
IngestDate Fri Jul 19 12:58:02 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Polish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PL1689370TT53
Notes Application Number: PL20040797879T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170929&DB=EPODOC&CC=PL&NR=1689370T5
ParticipantIDs epo_espacenet_PL1689370TT5
PublicationCentury 2000
PublicationDate 20170929
PublicationDateYYYYMMDD 2017-09-29
PublicationDate_xml – month: 09
  year: 2017
  text: 20170929
  day: 29
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies BAYER INTELLECTUAL PROPERTY GMBH
RelatedCompanies_xml – name: BAYER INTELLECTUAL PROPERTY GMBH
Score 3.1110327
Snippet Production of solid, orally administered pharmaceutical compositions (A) containing...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title METHOD FOR THE PRODUCTION OF A SOLID, ORALLY APPLICABLE PHARMACEUTICAL COMPOSITION COMPRISING 5-Chlor-N ( { (5-2-oxo-3- [4- (3-oxo-4-morpholinyl)-phenyl]-1, 3- oxazolidin-5-yl}-methyl)-2-thiophencarboxamide
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170929&DB=EPODOC&locale=&CC=PL&NR=1689370T5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Ra9tADD7arrR769qOLW2HBiOkUDHH9jnLQxiO7dQpds44zkgZo9iOTQNJHFqXNRv7i_tN05lk3Uv3dueT70FCJ-lO-sTYh2Z7YnAtSzHWkpQCFCPDWE9VzFoS7Txp58lE3kP6A8Md6VdjPt5i000tTIUT-r0CRySNSknfy-q8Xj5dYtlVbuX9x2RKn4rPvahj19fRcbOlkLmv292OEwhbWHXL6gRefRB2moY0zErEt9kL8qJbUhmcL11ZlLL816L0DthuQJstyldsazk7ZPvWpvHaIdvz1-_dNFyr3v0R--07kStsoKgNIteBIBT2qMoAAdEDE4bC69sXIELT867BDAJZI9z1iNA1Q9-0nFEkoQ_AEn4ghv3qRzkO-8P-4BI4WrcUuuMAGvATGhxVLB4L1BC-6ggNrZrpOC9ILrLPz2p2jjI9bDX7hs0LILriMf5BK2QLkeNq9gtlc2pJpmJ5O5XwBYs0vkuIbE6MP2bve05kuUiMufkrhJvA27Aw4tprtrMoFtkbBnoecyUxyEePNV2d5PGnXE9aeZurSqxkRvaW1Z7fp_a_xRP2UgpU5mao7VO2U949ZGfkAJTJu0p0fwAzva4r
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9NADD6NDTHeYIDYBsNIqCrSLNIkl9KHCqVJSgJJLkpTNIRQlaSJVqlrqi2IddP-4n7TfFE7eIG3u5xzD7Z8tu_sz4y96_SmBteKHFMtyylAMQpM9VzFoivRzrNemU3lPWQQGu5Y_3LCT7bYbFML0-CE_m7AEUmjctL3ujmvl38usewmt_LiQzajT9WnYdK3W-vouNNVyNy37EHfiYQtrJZl9SO_Fcb9jiENs5LwB2yHPOyuVAbn20AWpSz_tijDJ-xhRJst6qdsaznfY7vWpvHaHnsUrN-7abhWvYtn7DZwElfYQFEbJK4DUSzscZMBAmIIJoyE79nHIGLT97-DGUWyRnjgE6FrxoFpOeNEQh-AJYJIjLzmRzmOvZEXfgaO1imF7hhCG66hzVHF6rJCDeGHjtDWmpmOZxXJRfb5Wc3fo0wPW81_YucYiK66TK9ohWwhclzNb1A2p5ZkKtanMwlfsMjT84zIzojxz9nboZNYLhJjJvdCmET-hoUJ116w7UW1KF4y0MuUK5lBPnqq6eq0TD-WetYte1xVUqUwin128O99Dv63-IbtukngT3wv_HrIHkvhyjwNtfeKbdfnv4rX5AzU2VEjxjuOsrEe
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=METHOD+FOR+THE+PRODUCTION+OF+A+SOLID%2C+ORALLY+APPLICABLE+PHARMACEUTICAL+COMPOSITION+COMPRISING+5-Chlor-N+%28+%7B+%285-2-oxo-3-+%5B4-+%283-oxo-4-morpholinyl%29-phenyl%5D-1%2C+3-+oxazolidin-5-yl%7D-methyl%29-2-thiophencarboxamide&rft.inventor=BENKE%2C+KLAUS&rft.date=2017-09-29&rft.externalDBID=T5&rft.externalDocID=PL1689370TT5